ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,414Medicare Part D Prescriptions Filled, Including Refills

Rank: 341 out of 2588

$329K Total Retail Price of All Prescriptions

Rank: 943 out of 2588

663 Patients Receiving at Least One Drug in Part D
83%Patients 65 Years and Older
36% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Illinois
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

18% of this provider’s 663 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

3% of this provider’s 8,941 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

14% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$32 was the average price of a prescription from this provider, compared to $60 among peers.

Prescriptions per Patient

16 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Illinois
METOPROLOL TARTRATE 646 578 1 9
SIMVASTATIN 623 556 2 1
LISINOPRIL 619 549 3 3
FUROSEMIDE 509 451 4 5
HYDROCODONE-ACETAMINOPHEN 447 250 S3 5 7
AMLODIPINE BESYLATE 433 368 6 4
NIFEDIPINE ER 318 277 7 59
LOVASTATIN 282 277 8 34
GLYBURIDE 270 260 R 9 65
CLONIDINE HCL 256 228 10 54
TRIAMTERENE-HCTZ 234 205 11 46
METFORMIN HCL 223 184 12 8
BISOPROLOL-HYDROCHLOROTHIAZIDE 218 193 13 171
ACETAMINOPHEN-CODEINE 213 164 S3 14 80
LOSARTAN POTASSIUM 190 171 15 17
OMEPRAZOLE 179 126 16 6
NIFEDIAC CC 173 159 17 253
LEVOTHYROXINE SODIUM 140 120 18 2
WARFARIN SODIUM 138 120 19 10
DOXAZOSIN MESYLATE 127 104 20 96
KLOR-CON 10 114 109 21 75
CARVEDILOL 114 114 21 20
AZITHROMYCIN 109 84 23 45
HYDROCHLOROTHIAZIDE 106 103 24 13
CLOPIDOGREL 101 96 25 30
POTASSIUM CHLORIDE 95 84 26 15
VENTOLIN HFA 93 74 27 101
HYDRALAZINE HCL 93 76 27 53
LISINOPRIL-HYDROCHLOROTHIAZIDE 91 91 29 35
PLAVIX 90 87 30 43
ALLOPURINOL 89 89 31 33
DIOVAN 87 87 32 29
SPIRONOLACTONE 82 73 33 58
RANITIDINE HCL 75 75 34 37
KLOR-CON M20 74 57 35 52
INSULIN SYRINGE 70 55 36 81
ENALAPRIL MALEATE 69 54 37 31
DIGOXIN 60 49 38 38
METOPROLOL SUCCINATE 60 49 38 12
GLIPIZIDE 60 56 38 44
OXYBUTYNIN CHLORIDE 58 52 41 132
CIPROFLOXACIN HCL 57 39 42 82
ATENOLOL 51 42 43 14
ALENDRONATE SODIUM 51 51 43 21
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 11, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.